Telehealth Ketamine in North Dakota: Access, Laws, and What to Know

Telehealth ketamine in North Dakota is legal and available to residents statewide, overseen by the North Dakota Board of Medicine and federal DEA rules under the Ryan Haight Online Pharmacy Consumer Protection Act. North Dakota's broad nurse practitioner scope of practice and accommodating telehealth controlled substance rules make it one of the more accessible states for remote ketamine care, which matters given the state's vast rural distances and limited specialist availability. Ketamine is a Schedule III controlled substance, so a prescriber, whether a physician, nurse practitioner, or physician assistant, must establish a valid provider-patient relationship, typically through a real-time audio-visual evaluation, before prescribing.

As of 2026, federal DEA flexibilities generally allow this evaluation to happen without a prior in-person visit, though rules continue to evolve at both the state and federal level. Patients should verify current requirements with the North Dakota Board of Medicine before starting care.

Yes. Telehealth ketamine is legal in North Dakota under the federal Ryan Haight Online Pharmacy Consumer Protection Act, enforced by the DEA Diversion Control Division, and the state's telehealth practice rules under North Dakota Century Code Chapter 43-17. Ketamine is a Schedule III controlled substance, so a prescriber must establish a valid provider-patient relationship, typically through a real-time audio-visual evaluation, and document it according to North Dakota Board of Medicine standards. Prescribers must also check the state's Prescription Drug Monitoring Program before writing a ketamine prescription.

As of 2026, federal DEA flexibilities first extended during the COVID-19 public health emergency continue to allow many telehealth ketamine evaluations without a prior in-person visit, and North Dakota does not add a separate state-specific in-person requirement. This remains subject to ongoing federal rulemaking, so confirm current rules directly with the North Dakota Board of Medicine before scheduling care. For how this fits the national picture, see our telehealth legality overview.

North Dakota grants nurse practitioners full practice authority, which includes independent prescribing of Schedule III controlled substances like ketamine. This means the prescriber on a telehealth ketamine visit may be a physician, a nurse practitioner, or, depending on supervision rules, a physician assistant. Patients can confirm a specific prescriber's license and scope of practice through the North Dakota Board of Medicine or the North Dakota Board of Nursing.

In-state provider availability is limited to moderate. North Dakota's population is under 800,000, so the pool of local specialists is small, and residents of Fargo, Bismarck, and Grand Forks generally have more options than patients in Williston, Dickinson, or other rural areas. North Dakota participates in the Interstate Medical Licensure Compact, which lets physicians already licensed in other compact states obtain North Dakota licensure more efficiently, expanding the telehealth provider pool. Even so, wait times can run longer than in more populated states. Read our guide on how to get a ketamine prescription online for the general steps. You can also compare North Dakota's rules with other states in our state-by-state ketamine regulations guide.

North Dakota Medicaid, administered by the state Department of Health and Human Services, may cover Spravato (esketamine) with prior authorization when a patient meets treatment-resistant depression criteria, but it does not typically cover off-label ketamine for mental health indications. Commercial insurance follows a similar pattern nationally: Spravato is more often covered when diagnostic criteria are met, while compounded oral, sublingual, and IM ketamine used off-label is generally self-pay. See our insurance versus cash-pay ketamine guide for the broader national picture.

Typical self-pay costs for North Dakota patients range from about $200 to $450 for an initial evaluation and $75 to $250 per month for ongoing treatment, though exact pricing varies by provider and formulation. Confirm current coverage and prior authorization requirements directly with your plan before starting treatment.

Most North Dakota patients receive compounded ketamine, such as sublingual troches or rapid-dissolve tablets, by mail from national compounding pharmacies licensed to ship into the state, since few compounding facilities operate in-state. The North Dakota Board of Pharmacy regulates compounding activity and requires USP compliance. Because of the state's remote geography, shipping times can run slightly longer than in more centrally located states, so patients should plan medication refills in advance, particularly during winter months.